A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
Please provide your email address to receive an email when new articles are posted on . Drugs that treat systemic diseases can be lifesaving, but when these drugs lead to poor ocular health or vision, ...
Several studies have evaluated patch testing for the diagnosis of drug eruptions, but widespread acceptance of this procedure is lacking in North America. The objective of this review is to address ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results